Global private credit giants are increasingly turning to Asia-Pacific as a key growth frontier, driven by widening funding gaps, evolving capital markets, and the retreat of traditional bank lending, according to a report by CNBC citing data from PitchBook.
Palamon Capital Partners, a pan-European growth investor, has agreed to sell its majority stake in mydentist, to funds managed by Bridgepoint Advisors, marking the conclusion of a transformative partnership with the company’s management team since Palamon’s acquisition of a majority stake in 2021.
BC Partners and Pollen Street Capital are moving forward with plans to float Shawbrook Bank in London, with an initial public offering expected as early as the second half of 2025, according to a report by the Financial Times citing sources familiar with the process.
K1 Investment Management, a small-cap enterprise software investor, has entered into a definitive agreement to exit its portfolio company Subsplash to Roper Technologies, a member of the S&P 500.
The private equity backers of MasOrange are exploring options to sell their collective 50% stake in the Spanish telecoms joint venture, with an initial valuation target of at least €5bn ($5.9bn), according to a report by Bloomberg citing sources familiar with the matter.
Advent International-backed NIQ Global Intelligence has raised $1.05bn in its US initial public offering, pricing 50 million shares at $21 each – the midpoint of its marketed $20-$24 range, according to a report by Bloomberg.
Dedicated NAV finance provider 17Capital has held the final close of 17Capital Strategic Lending Fund 6, with approximately $5.5bn of commitments, including co-investment and affiliated vehicles.
Private credit giants HPS Investment Partners and Arcmont Asset Management have provided €25m in fresh funding to embattled Italian sportswear manufacturer Dainese, as negotiations intensify over a potential debt-for-equity takeover, according to a report by Bloomberg.
Private equity firms are increasingly turning to continuation funds to exit ageing investments, with deals totalling $41bn in the first half of 2025 — a record figure that accounted for 19% of all industry exits, according to a report by the Financial Times citing new data from Jefferies.
CapVest Partners is in advanced discussions to acquire a majority stake in German pharmaceutical firm Stada Arzneimittel, in a potential transaction that could value the business at approximately €10bn ($11.7bn), including debt, according to a report by Bloomberg.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
